These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 30024982

  • 1. Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis.
    Zhang R, Xi X, Wang C, Pan Y, Ge C, Zhang L, Zhang S, Liu H.
    PLoS One; 2018; 13(7):e0201025. PubMed ID: 30024982
    [Abstract] [Full Text] [Related]

  • 2. Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy.
    Johnson BJ, Ress SR, Willcox P, Pati BP, Lorgat F, Stead P, Saha R, Lukey P, Laochumroonvorapong P, Corral L.
    Cytokines Mol Ther; 1995 Sep; 1(3):185-96. PubMed ID: 9384675
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placebo.
    Johnson BJ, Bekker LG, Rickman R, Brown S, Lesser M, Ress S, Willcox P, Steyn L, Kaplan G.
    Tuber Lung Dis; 1997 Sep; 78(3-4):195-203. PubMed ID: 9713652
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of Adjunctive Recombinant Human Interleukin-2 for Patients with Pulmonary Tuberculosis: A Meta-Analysis.
    Sheng L, Li X, Weng F, Wu S, Chen Y, Lou L.
    J Trop Med; 2022 Sep; 2022():5071816. PubMed ID: 36467716
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of vitamin D supplementation on the outcome of pulmonary tuberculosis treatment in adults: a meta-analysis of randomized controlled trials.
    Zhang J, Chen C, Yang J.
    Chin Med J (Engl); 2019 Dec 20; 132(24):2950-2959. PubMed ID: 31833904
    [Abstract] [Full Text] [Related]

  • 7. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A, Gelaw B, Wang SH, Tessema B.
    PLoS One; 2018 Dec 20; 13(6):e0198080. PubMed ID: 29944658
    [Abstract] [Full Text] [Related]

  • 8. Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): A systematic review of randomised clinical trials.
    Wang M, Guan X, Chi Y, Robinson N, Liu JP.
    Tuberculosis (Edinb); 2015 Jul 20; 95(4):364-72. PubMed ID: 25861717
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.
    Huang CY, Hsieh WY.
    Hum Vaccin Immunother; 2017 Sep 02; 13(9):1960-1971. PubMed ID: 28604170
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant data.
    Jolliffe DA, Ganmaa D, Wejse C, Raqib R, Haq MA, Salahuddin N, Daley PK, Ralph AP, Ziegler TR, Martineau AR.
    Eur Respir J; 2019 Mar 02; 53(3):. PubMed ID: 30728208
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of undernutrition on sputum culture conversion and treatment outcomes among people with multidrug-resistant tuberculosis: a systematic review and meta-analysis.
    Wagnew F, Alene KA, Kelly M, Gray D.
    Int J Infect Dis; 2023 Feb 02; 127():93-105. PubMed ID: 36481489
    [Abstract] [Full Text] [Related]

  • 15. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.
    Chien JY, Chen YT, Shu CC, Lee JJ, Wang JY, Yu CJ, Yang PC.
    Chest; 2013 Jun 02; 143(6):1725-1732. PubMed ID: 23288018
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis.
    Alene KA, Viney K, Yi H, McBryde ES, Yang K, Bai L, Gray DJ, Xu Z, Clements ACA.
    PLoS One; 2018 Jun 02; 13(5):e0197880. PubMed ID: 29791488
    [Abstract] [Full Text] [Related]

  • 17. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA, Burhan E, Nawas A, Soepandi PZ, Sutoyo DK, Agustin H, Isbaniah F, Dowdy DW.
    Int J Tuberc Lung Dis; 2014 May 02; 18(5):564-70. PubMed ID: 24903794
    [Abstract] [Full Text] [Related]

  • 18. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol.
    Condos R, Rom WN, Schluger NW.
    Lancet; 1997 May 24; 349(9064):1513-5. PubMed ID: 9167461
    [Abstract] [Full Text] [Related]

  • 19. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV, Balasubramanian R, Swaminathan S, Ramachandran R, Rahman F, Sundaram V, Thyagarajan K, Selvakumar N, Adhilakshmi AR, Iliayas S, Narayanan PR.
    Indian J Med Res; 2007 Nov 24; 126(5):452-8. PubMed ID: 18160750
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
    Mlotshwa M, Abraham N, Beery M, Williams S, Smit S, Uys M, Reddy C, Medina-Marino A.
    BMC Infect Dis; 2016 Aug 02; 16():365. PubMed ID: 27484399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.